Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers

A Clinical Trial to Evaluate the Efficacy and Safety of DR-2011 for In Vitro Fertilization

ClinicalTrials.gov ID: NCT00615251

Public ClinicalTrials.gov record NCT00615251. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 3:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Single-Blind, Randomized Study to Compare DR-2011 to a Progesterone Gel for Luteal Phase Supplementation for In Vitro Fertilization

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multi-center study to evaluate the effects of DR-2011 compared to a progesterone gel in women undergoing in vitro fertilization with fresh eggs. The overall study duration will be approximately 12 months and will involve ovarian suppression/stimulation protocols as well as egg retrieval.

Study identification

NCT ID
NCT00615251
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Duramed Research
Industry
Enrollment
1,297 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 42 Years
Sex
Female
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2008 (Type not available)
Primary completion
Aug 2009 (Actual)
Completion
Aug 2009 (Actual)
Last update posted
Sep 13, 2013

2008 – 2009

United States locations

U.S. sites
29
U.S. states
14
U.S. cities
29
Facility City State ZIP Site status
Duramed Investigational Site Tarzana California 91356 —
Duramed Investigational Site West Los Angeles California 90064 —
Duramed Investigational Site Westlake California 91361 —
Duramed Investigational Site Clearwater Florida 33759 —
Duramed Investigational Site Alpharetta Georgia 30005 —
Duramed Investigational Site Atlanta Georgia 30342 —
Duramed Investigational Site Boise Idaho 83702 —
Duramed Investigational Site Chicago Illinois 60610 —
Duramed Investigational Site Highland Park Illinois 60035 —
Duramed Investigational Site Rockville Maryland 20850 —
Duramed Investigational Site Dearborn Michigan 48126 —
Duramed Investigational Site Flint Michigan 48503 —
Duramed Investigational Site Rochester Hills Michigan 48307 —
Duramed Investigational Site Saginaw Michigan 48604 —
Duramed Investigational Site Ypsilanti Michigan 48197 —
Duramed Investigational Site Woodbury Minnesota 55125 —
Duramed Investigational Site Reno Nevada 89511 —
Duramed Investigational Site Marlton New Jersey 08053 —
Duramed Investigational Site Morristown New Jersey 07960 —
Duramed Investigational Site Cincinnati Ohio 45209 —
Duramed Investigational Site Sylvania Ohio 43560 —
Duramed Investigational Site Columbia South Carolina 29201 —
Duramed Investigational Site Mt. Pleasant South Carolina 29464 —
Duramed Investigational Site Myrtle Beach South Carolina 29577 —
Duramed Investigational Site Austin Texas 78731 —
Duramed Investigational Site Beaumont Texas 77706 —
Duramed Investigational Site Bedford Texas 76022 —
Duramed Investigational Site Webster Texas 77598 —
Duramed Investigational Site Norfolk Virginia 23507 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00615251, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 13, 2013 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00615251 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →